Antje B.
- Country
- Germany
- Department
- Department of Clinical Pharmacology and Pharmacoepidemiology
Research Overview
- Evaluation of Safety, Tolerability, and Pharmacokinetics of Ascending Single Oral Doses of Octreotide/LipOra Peptide in Healthy Volunteers with Acromegaly
- Safety and Pharmacokinetic Evaluation of Nurandociguat in Combination with Nitroglycerin in Patients with Coronary Artery Disease
- Randomized Adaptive Trial of Bupropion Hydrochloride for Fatigue in Post‑COVID‑19 Syndrome (RAPID‑ELAPSE)
Data & Insights
Has run more than one trial at 9 of 39 partner sites.
Specializations
Pharmacology and Drug Interactions
The investigator specializes in studying pharmacokinetic interactions and drug metabolism, with particular focus on examining the effects of medications like metamizole and tacrolimus. Their research extends to understanding how the gut microbiome influences drug absorption and metabolism.
- Drug-drug interactions
- Metabolic pathways analysis
- Microbiome-drug relationships
Gastrointestinal and Hepatic Disorders
Their research encompasses therapeutic approaches for Primary Sclerosing Cholangitis (PSC) and studies of norucholic acid. The investigator also conducts research on innovative treatments using fecal microbiota transfer for addressing antibiotic-resistant infections.
- Liver disease therapeutics
- Microbiota-based treatments
- Antimicrobial resistance
Endocrine and Renal Studies
The investigator focuses on treatments for adrenal insufficiency and focal segmental glomerulosclerosis. Their work includes studying novel drug delivery methods and investigating treatments for acromegalia.
- Hormone replacement therapy
- Kidney disease treatments
- Drug delivery systems
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.